Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junping Shi

Showing results (21-30 of 178) with videos related to

Pageof 18
Sort By:
Materials (Basel, Switzerland)|January 18, 2019
Asymptotic Solution and Numerical Simulation of Lamb Waves in Functionally Graded Viscoelastic FilmXiaoshan Cao, Haining Jiang, Yan Ru, et al.
Journal of Clinical and Translational Hepatology|May 25, 2026
Guidelines for Diagnosis and Management of Metabolic Dysfunction-associated Fatty Liver Disease in Primary Care (2025)Wenjing Ni, Junping Shi, Jian-Gao Fan, et al.
Journal of Mathematical Biology|April 23, 2013
Spatiotemporal mutualistic model of mistletoes and birdsChuncheng Wang, Rongsong Liu, Junping Shi, et al.
Journal of Affective Disorders|January 5, 2022
Association between nonalcoholic fatty liver disease and depression: A systematic review and meta-analysis of observational studiesYunpeng Gu, Wei Zhang, Yanli Hu, et al.
Diagnostic Microbiology and Infectious Disease|July 30, 2024
Hepatitis E virus and SARS-CoV-2 co-infection in an immunocompromised patient: A case reportChun Liu, Dong Tang, Junping Shi, et al.
Oncotargets and Therapy|December 28, 2020
Mutational Characterization and Potential Prognostic Biomarkers of Chinese Patients with Esophageal Squamous Cell CarcinomaNan Zhang, Junping Shi, Xiaoliang Shi, et al.
Clinical and Molecular Hepatology|June 18, 2024
Metabolic dysfunction-associated fatty liver disease related hepatocellular carcinoma in China: An increasing problem: Letter to the edior on "Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis"Xiangyu Wu, Wenjing Ni, Qianqian Chen, et al.
Journal of Hepatology|July 22, 2024
Superior diagnostic efficacy of Agile 3+ score for diagnosing advanced fibrosis in patients with chronic hepatitis B and concurrent metabolic dysfunction-associated steatotic liver diseaseFajuan Rui, Wenjing Ni, Junping Shi, et al.
The Oncologist|February 27, 2020
Efficacy of Cabozantinib and Nivolumab in Treating Hepatocellular Carcinoma with RET Amplification, High Tumor Mutational Burden, and PD-L1 ExpressionXiaobo Yang, Junping Shi, Xiaoqian Chen, et al.
Gut and Liver|September 27, 2019
The Role of Intestinal Fungi and Its Metabolites in Chronic Liver DiseasesNingning You, Lili Zhuo, Jingxin Zhou, et al.
Pageof 18

Showing results (21-30 of 178) with videos related to

Sort By:
Pageof 18
Materials (Basel, Switzerland)|January 18, 2019
Asymptotic Solution and Numerical Simulation of Lamb Waves in Functionally Graded Viscoelastic FilmXiaoshan Cao, Haining Jiang, Yan Ru, et al.
Journal of Clinical and Translational Hepatology|May 25, 2026
Guidelines for Diagnosis and Management of Metabolic Dysfunction-associated Fatty Liver Disease in Primary Care (2025)Wenjing Ni, Junping Shi, Jian-Gao Fan, et al.
Journal of Mathematical Biology|April 23, 2013
Spatiotemporal mutualistic model of mistletoes and birdsChuncheng Wang, Rongsong Liu, Junping Shi, et al.
Journal of Affective Disorders|January 5, 2022
Association between nonalcoholic fatty liver disease and depression: A systematic review and meta-analysis of observational studiesYunpeng Gu, Wei Zhang, Yanli Hu, et al.
Diagnostic Microbiology and Infectious Disease|July 30, 2024
Hepatitis E virus and SARS-CoV-2 co-infection in an immunocompromised patient: A case reportChun Liu, Dong Tang, Junping Shi, et al.
Oncotargets and Therapy|December 28, 2020
Mutational Characterization and Potential Prognostic Biomarkers of Chinese Patients with Esophageal Squamous Cell CarcinomaNan Zhang, Junping Shi, Xiaoliang Shi, et al.
Clinical and Molecular Hepatology|June 18, 2024
Metabolic dysfunction-associated fatty liver disease related hepatocellular carcinoma in China: An increasing problem: Letter to the edior on "Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis"Xiangyu Wu, Wenjing Ni, Qianqian Chen, et al.
Journal of Hepatology|July 22, 2024
Superior diagnostic efficacy of Agile 3+ score for diagnosing advanced fibrosis in patients with chronic hepatitis B and concurrent metabolic dysfunction-associated steatotic liver diseaseFajuan Rui, Wenjing Ni, Junping Shi, et al.
The Oncologist|February 27, 2020
Efficacy of Cabozantinib and Nivolumab in Treating Hepatocellular Carcinoma with RET Amplification, High Tumor Mutational Burden, and PD-L1 ExpressionXiaobo Yang, Junping Shi, Xiaoqian Chen, et al.
Gut and Liver|September 27, 2019
The Role of Intestinal Fungi and Its Metabolites in Chronic Liver DiseasesNingning You, Lili Zhuo, Jingxin Zhou, et al.
Pageof 18